HOOKIPA Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	40.28	39.68	117.1	112.49	65.92	142.74
Cash & Short-Term Investments	40.28	39.68	117.1	112.49	65.92	142.74
Cash Growth	-56.58%	-66.11%	4.10%	70.64%	-53.82%	26.15%
Accounts Receivable	0.55	0.29	0.51	6.53	6.9	5.54
Other Receivables	7.76	23.38	18.76	15.48	14.27	15.12
Receivables	8.31	23.67	19.27	22.01	21.17	20.66
Prepaid Expenses	9.08	15	10.75	12.16	14.48	8.1
Restricted Cash	0.1	0.1	-	0.54	0.57	-
Other Current Assets	2.33	2.22	-	-	-	-
Total Current Assets	60.09	80.67	147.12	147.2	102.14	171.5
Property, Plant & Equipment	0.69	1.06	13.22	21.98	22.12	13.97
Other Long-Term Assets	0.48	0.82	1.01	1.28	1.8	2.34
Total Assets	61.26	82.55	161.34	170.45	126.05	187.82
Accounts Payable	3.67	8.69	12.5	5.49	8.76	8.01
Accrued Expenses	9.02	9.81	11.67	10.65	8.16	6.35
Current Portion of Long-Term Debt	-	-	1.12	1.59	2.79	-
Current Portion of Leases	0.31	0.55	1.64	1.69	1.7	2.15
Current Income Taxes Payable	-	-	0.37	0.23	-	-
Current Unearned Revenue	3.63	4.76	14.68	15.98	6.23	4.63
Other Current Liabilities	-	0.84	0.01	-	0.01	-
Total Current Liabilities	16.64	24.65	41.99	35.63	27.65	21.14
Long-Term Debt	-	-	-	0.91	2.22	4.54
Long-Term Leases	0.28	0.32	3.8	2.31	3.91	4.08
Long-Term Unearned Revenue	0.57	0.73	19.67	25.66	0.02	0.78
Other Long-Term Liabilities	9.69	5.63	6.02	3.42	2.65	1.15
Total Liabilities	27.18	31.33	71.48	67.94	36.45	31.69
Common Stock	0	0	0	0.01	0	0
Additional Paid-In Capital	468.71	469.06	467.05	397.35	317.14	309.29
Retained Earnings	-428.19	-412.76	-369.26	-287.68	-222.77	-147.1
Comprehensive Income & Other	-6.44	-5.09	-7.93	-7.16	-4.78	-6.07
Total Common Equity	34.08	51.21	89.86	102.52	89.59	156.12
Shareholders' Equity	34.08	51.21	89.86	102.52	89.59	156.12
Total Liabilities & Equity	61.26	82.55	161.34	170.45	126.05	187.82
Total Debt	0.6	0.88	6.56	6.5	10.63	10.77
Net Cash (Debt)	39.68	38.81	110.54	105.99	55.3	131.98
Net Cash Growth	-54.22%	-64.89%	4.29%	91.67%	-58.10%	30.93%
Net Cash Per Share	3.17	3.10	11.69	16.18	16.84	50.68
Filing Date Shares Outstanding	12.67	12.54	12.54	7.22	5.64	2.98
Total Common Shares Outstanding	12.56	12.54	12.54	7.22	3.29	2.98
Working Capital	43.45	56.01	105.13	111.56	74.48	150.36
Book Value Per Share	2.71	4.08	7.17	14.20	27.23	52.45
Tangible Book Value	34.08	51.21	89.86	102.52	89.59	156.12
Tangible Book Value Per Share	2.71	4.08	7.17	14.20	27.23	52.45
Land	-	-	2.03	1.96	2.07	-
Machinery	1.75	2.96	12.03	10.06	9.55	7.97
Construction In Progress	-	0.01	0.21	10.57	7.75	0.03
Leasehold Improvements	-	3.1	3.3	3.16	3.35	3.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.